Does Dr. MARIE VEE ALBARILLO have financial conflicts of interest?

Dr. MARIE VEE ALBARILLO (PA) has received a total of $1,108 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,108 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MARIE VEE ALBARILLO?

According to CMS Open Payments data, Dr. MARIE VEE ALBARILLO received funding from STRYKER CORPORATION ($762), DENDREON PHARMACEUTICALS ($140), and SPR THERAPEUTICS ($121).

Does Dr. MARIE VEE ALBARILLO receive research grants or speaking fees?

Dr. MARIE VEE ALBARILLO has received $1,108 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MARIE VEE ALBARILLO

PAReal-Time Hydrated

Specialty: Physician Assistant

Practice Location: NEW ROCHELLE, NY 10801

NPI Number: 1285734053

LIFETIME INDUSTRY VALUE

$1,108

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALBARILLO is a verified Physician Assistant practitioner based in NEW ROCHELLE, NY.

Between 2021 and 2025, Dr. ALBARILLO had an overall industry promotional and research financial footprint of $1,108 as recorded in the federal CMS Open Payments database.

$1,108 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALBARILLO's primary funding source is STRYKER CORPORATION, which accounts for $762 (representing 68.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

STRYKER CORPORATION

Rank 1

$762

68.7%

DENDREON PHARMACEUTICALS

Rank 2

$140

12.6%

SPR THERAPEUTICS

Rank 3

$121

10.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.